Independent Directors of 23andMe Resign from Board

1 year ago

SOUTH SAN FRANCISCO, Calif., Sept. 17, 2024 (GLOBE NEWSWIRE) -- The independent directors of the Board of 23andMe Holding Co.…

Awakn Life Sciences Announces Upsizing and Closing of Tranche of Private Placement Financing

1 year ago

Toronto, Ontario--(Newsfile Corp. - September 18, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF) (FSE: 954) ("Awakn" or…

Therma Bright Announces Shares for Debt Issuance to Include Portfolio Company AI4LYF & IR Agreement

1 year ago

Toronto, Ontario--(Newsfile Corp. - September 18, 2024) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma Bright" or the "Company"),…

TVM Capital Healthcare Announces Investment in Human Longevity, Inc. as Part of its Strategy of Supporting Disease Prevention and Healthy Aging

1 year ago

HLI is one of the most established, global longevity science companies and committed to accelerating living to 100+ years of…

Tetra Pharm Technologies Relocates to Copenhagen Towers

1 year ago

COPENHAGEN, Denmark, Sept. 18, 2024 /PRNewswire/ -- Tetra Pharm Technologies are thrilled to announce the relocation of headquarters to Copenhagen…

Clarivate Announces 15th Annual Pharmavision India Conference Agenda

1 year ago

Industry leaders to discuss AI in healthcare, cell and gene therapy, market access and more at premier life sciences event…

Xtant Medical Expands Product Portfolio with Launch of its own Viable Bone Matrix, OsteoVive(R) Plus

1 year ago

New Cellular Bone Matrix Designed with Cohesive and Moldable Handling Characteristics BELGRADE, MT / ACCESSWIRE / September 18, 2024 /…

Bioz Stars Revolutionizes Product Selection in Scientific Research With Objective Ratings

1 year ago

PALO ALTO, CA / ACCESSWIRE / September 18, 2024 / Bioz, Inc., a pioneer in AI-driven research solutions, proudly highlights…

IRLAB Granted Additional Patent for its Drug Candidate Pirepemat Expanding the Patent Protection in the US

1 year ago

GOTHENBURG, SE / ACCESSWIRE / September 18, 2024 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA) Gothenburg, Sweden, September 18, 2024 - IRLAB…

Relief Therapeutics Completes Clinical Phase in RLF-OD032 Proof-of-Concept Study; Topline Results Expected in October 2024

1 year ago

GENEVA, SWITZERLAND / ACCESSWIRE / September 18, 2024 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY ) (Relief, or the Company), a…